Eventzilla

14th Annual Infectious Diseases Update

Friday, May 5, 2023 at 9:00 AM to 1:00 PM EDT

1300 York Avenue, New York, New York, 10065, United States

Registration

Access code applied successfully. Remove

Invalid access code. Try again
Have an access code?

Sale ended

In-Person General Admission Partial Approval - $30.00

In-Person General Admission Registration fee to be paid to Weill Cornell Medicine inclusive of: admission to program, course materials and refreshments.

sales ended

Virtual General Admission Partial Approval - $30.00

Virtual attendance via ZOOM registration fee to be paid to Weill Cornell Medicine inclusive of: admission to program and course materials.

Enter your discount code

Subtotal (excluding fees and discounts)
Fee
Total amount

Event Information

Friday, May 5, 2023 at 9:00 AM to 1:00 PM EDT

Uris Auditorium, 1300 York Avenue, New York, New York, 10065, United States.

Weill Cornell Medicine - Division of Infectious Diseases is proud to present our 14th Annual Infectious Diseases Update.

This program will provide attendees with information on:

New Antifungal Therapies in 2023
ABC's and AUC's of Therapeutic Drug Monitoring
Updates on Vaccines for Children and Adults
Changing Paradigms in treating C. difficile infection
Long - Acting Injectable Antiretroviral Therapy for HIV Treatment and Prevention

Target Audience: The conference is intended for primary care providers (internists, family care practitioners) and infectious disease and HIV specialists, including, physicians, nurse practitioners and physician assistants. Anyone who is interested in this program is welcome to attend.

*REGISTRATION FEE: $30 (Free for Residents, Fellows and Medical Students)

*Registration fee to be paid to Weill Cornell Medicine inclusive of: admission to program and course materials (coffee break will be provided for in-person attendees).

Accreditation Statement: Weill Cornell Medical College is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Weill Cornell Medical College designates this live activity for a maximum of 3.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Statement: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3.5 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Upon successful completion of this course, Weill Cornell Medical College will submit your completion data to ABIM via ACCME’s Program and Activity Reporting System (PARS) for MOC points.

Speakers

Learn more aboutMarshall Glesby, MD, PhD

Marshall Glesby, MD, PhD

Professor of Medicine and Population Health Sciences, Associate Chief, Division of Infectious Diseases

Weill Cornell Medicine

Dr. Glesby is a Professor of Medicine and Healthcare Policy and Research and Regional Director of the Northeast Caribbean AIDS Education and Training Center (AETC). Dr. Glesby trained in internal medicine and in infectious diseases at Johns Hopkins and received a Ph.D. in clinical investigation from the Johns Hopkins School of Hygiene and Public Health. His research interests include metabolic, cardiopulmonary, and aging-related complications in people living with HIV. He also collaborates with colleagues in Brazil on studies of HTLV-I infection and leishmaniasis. Dr. Glesby directs the HIV/AIDS Clinical Trials Unit at Weill Cornell and is the Director of the Clinical and Translational Research Unit Core of Weill Cornell Clinical and Translational Science Center.

Learn more aboutRoy Gulick, MD

Roy Gulick, MD

Rochelle Belfer Professor of Medicine Chief, Division of Infectious Diseases

Weill Cornell Medicine

Dr. Gulick is the Rochelle Belfer Professor in Medicine and Chief of the Division of Infectious Diseases at Weill Cornell Medicine. Dr. Gulick trained in internal medicine at Columbia and in infectious diseases at Harvard and received his MPH in clinical trial design from the Harvard School of Public Health. His research focuses on clinical trials of antiretroviral therapies for treatment and prevention of HIV infection. Dr. Gulick currently serves as Principal Investigator of the Weill Cornell Medical College-New Jersey Medical School Clinical Trials Unit of the NIH-sponsored AIDS Clinical Trials Group (ACTG). He also serves as Co-Chair of the U.S. Department of Health and Human Services Panel for Clinical Practices for Treatment of HIV Infection (DHHS Guidelines Panel), Chair of NIH Office of AIDS Research Advisory Committee (OARAC) and is a Board Member of the International Antiviral Society-USA. Current projects include evaluating treatment strategies for both antiretroviral therapy-naïve and experienced patients, and using antiretroviral therapy as a prevention strategy (PrEP, pre-exposure prophylaxis).

Learn more aboutMichael Satlin, MD, MS

Michael Satlin, MD, MS

Associate Professor of Medicine Clinical Director of the Transplantation-Oncology Infectious Diseases Program

Division of Infectious Diseases, Weill Cornell Medicine

Dr. Satlin is an infectious diseases physician and Associate Professor of Medicine and Associate Professor of Pathology and Laboratory Medicine at Weill Cornell Medicine. He is the Clinical Director of the Transplantation-Oncology Infectious Diseases Program at Weill Cornell. He completed medical school at the University of Virginia School of Medicine and internal medicine residency and fellowship training at NewYork-Presbyterian Hospital/Weill Cornell. He also obtained a Master’s Degree in Clinical and Translational Investigation at Weill Cornell. His research focuses on the epidemiology, prevention, and treatment of multidrug-resistant Gram-negative infections, with a particular focus on immunocompromised hosts. He has an R01 grant through the National Institute of Allergy and Infectious Diseases (NIAID) to investigate the role of screening for resistant enteric bacteria to personalized infection prevention strategies in neutropenic patients. He is on the Editorial Advisory Boards of Clinical Infectious Diseases and Open Forum Infectious Diseases and Associate Editor for Journal of Antimicrobial Chemotherapy-Antimicrobial Resistance. He has authored or co-authored over 70 peer-reviewed manuscripts. He is a Member of the Clinical and Laboratory Standards Institute’s (CLSI) Subcommittee on Antimicrobial Susceptibility Testing and Co-Chair of its Breakpoint Working Group. Lastly, he serves on the ASM Microbe Program Committee and is a Member of multiple committees for the NIAID’s Antibacterial Resistance Leadership Group.

Learn more aboutChristine J. Kubin, PharmD, BCIDP

Christine J. Kubin, PharmD, BCIDP

Clinical Pharmacist, Infectious Diseases/Antimicrobial Stewardship

NewYork-Presbyterian Hospital Columbia University Irving Medical Center

Dr. Kubin received her PharmD from the University of North Carolina at Chapel Hill. After completing a PGY1 Pharmacy Practice Residency at the Bronx VA Medical Center, she joined the clinical pharmacy team at NewYork-Presbyterian Hospital in 1999. Dr. Kubin is currently a Clinical Pharmacy Specialist in Infectious Diseases and Pharmacy Leader for Antimicrobial Stewardship at NewYork-Presbyterian Hospital. She is a Board Certified Pharmacotherapy Specialist in Pharmacotherapy and Infectious Diseases and an Instructor in Clinical Medicine at Columbia University Vagelos College of Physicians and Surgeons. In her current role, Dr. Kubin co-directs the antimicrobial stewardship program and maintains a clinical practice in general adult and transplant ID. She has collaborated with pharmacy, physician, and microbiology colleagues to produce numerous peer-reviewed publications with a focus on antimicrobial-resistant organisms, antimicrobial stewardship, and invasive fungal infections.

Learn more aboutCarl Victor Crawford, Jr., MD

Carl Victor Crawford, Jr., MD

Assistant Professor of Clinical Medicine Program Director, Fellowship in Gastroenterology & Hepatology

Weill Cornell Medicine

Dr. Carl V. Crawford is an Assistant Professor of Clinical Medicine and Attending Physician at New York Presbyterian-Weill Cornell Medicine in the Division of Gastroenterology and Hepatology. Dr. Crawford completed his undergraduate studies at Georgetown University with a degree in Biology and minor in Theology. He received his medical degree from the Yale University School of Medicine while completing a concurrent Howard Hughes Medical Institute Research Fellowship in the area of parasitology. He attended Weill Cornell for his Medicine residency training and received a T-32 Training Award to study phytochemicals in the prevention of solid tumors through the Department of Surgery. He stayed on as a gastroenterology fellow at Cornell and has remained on faculty, serving as a GI specialist for the critically ill with an emphasis on pre-heart transplant patients and bone marrow transplant recipients. He is the current Program Director for the Gastroenterology and Hepatology Fellowship at Weill Cornell. His academic interests reside in the evaluation and management of enteric infections especially C. difficile infection (CDI) and provides fecal microbiota transfers for patients with recurrent and refractory cases of CDI. This work has allowed him to engage in other research areas that involve the microbiome in horizontal transfer of multi-drug resistance genes, colon cancer, IBD and Parkinson’s disease. He has been involved in a number of microbiota related C. difficile clinical trials as well aimed to reduce recurrent C. difficile infections. He is a member of the American College of Gastroenterology, the American Gastroenterological Association, and the NY society of Gastroenterology and Endoscopy

Learn more aboutKaren P. Acker, MD

Karen P. Acker, MD

Assistant Professor of Clinical Pediatrics

Pediatric Infectious Diseases Hospital Epidemiologist New York Presbyterian-Weill Cornell Medicine

Dr. Karen Acker is an Assistant Professor in Clinical Pediatrics at Weill Cornell Medicine and Pediatric Hospital Epidemiologist at NYP/ Komansky Children’s Hospital. After completing her fellowship in pediatric infectious diseases at Columbia University Medical Center in 2018, she joined the Pediatric Infectious Disease division at Weill Cornell Medicine, and has served as a Hospital Epidemiologist since 2019. She received her medical degree from SUNY Downstate Medical Center followed by a residency in pediatrics at Weill Cornell Medicine. Her clinical and research interests include the epidemiology of infectious outbreaks and hospital-acquired infections, diagnostic stewardship, and COVID-19 and multisystem inflammatory syndrome in children (MIS-C) in pediatrics.

Learn more aboutMarkus Plate, MD

Markus Plate, MD

Assistant Professor of Clinical Medicine

Weill Cornell Medicine Division of Infectious Diseases- Transplantation-Oncology Program

Dr. Plate received his MD from University of Mainz in Germany and post doctoral training at Peking University in China and USC in Los Angeles, CA. He then completed his Internal Medicine residency at Lincoln Medical Health Center in 2016 followed by an Infectious Diseases Fellowship at Memorial Sloan Kettering Cancer Center 2016-2018 and then joined the Infectious Diseases Faculty, transplantation-oncology program at WCM in 2018 where he is currently an Assistant Professor of Clinical Medicine

Learn more aboutS. Evan Cooper, MD, MS

S. Evan Cooper, MD, MS

Instructor in Medicine

Weill Cornell Medicine

Dr. Stanley Evan Cooper is an Instructor in Medicine in the Division of Infectious Diseases at Weill Cornell Medicine, where he currently practices as an HIV primary care provider in the Center for Special Studies at New York Presbyterian-Weill Cornell. He completed his internal medicine residency at Georgetown University Hospital and his infectious diseases fellowship at NewYork-Presbyterian-Weill Cornell. His areas of clinical and research expertise include HIV/STI treatment and prevention.

Event Schedule

Welcome
Register
Learning
Programming
Advantages
Workshop
Managemet
Programs
test
- test

09:00 AM